| 000 | 02518 a2200673 4500 | ||
|---|---|---|---|
| 005 | 20250516215359.0 | ||
| 264 | 0 | _c20141229 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1435-1803 | ||
| 024 | 7 |
_a10.1007/s00395-014-0421-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFraccarollo, Daniela | |
| 245 | 0 | 0 |
_aSoluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition. _h[electronic resource] |
| 260 |
_bBasic research in cardiology _cJul 2014 |
||
| 300 |
_a421 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Communication |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEnzyme Activators _xpharmacology |
| 650 | 0 | 4 |
_aExtracellular Matrix _xmetabolism |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xmetabolism |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitochondria, Heart _xdrug effects |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aMyofibroblasts _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aRamipril _xpharmacology |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xmetabolism |
| 650 | 0 | 4 | _aSoluble Guanylyl Cyclase |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
| 650 | 0 | 4 |
_aortho-Aminobenzoates _xpharmacology |
| 700 | 1 | _aGaluppo, Paolo | |
| 700 | 1 | _aMotschenbacher, Stephanie | |
| 700 | 1 | _aRuetten, Hartmut | |
| 700 | 1 | _aSchäfer, Andreas | |
| 700 | 1 | _aBauersachs, Johann | |
| 773 | 0 |
_tBasic research in cardiology _gvol. 109 _gno. 4 _gp. 421 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00395-014-0421-1 _zAvailable from publisher's website |
| 999 |
_c23898387 _d23898387 |
||